Clinical analysis for the efficacy of the treatment with hemoptysis and chronic hemosputum -A retrospective, single center, observational study-

Clinical analysis for the efficacy of the treatment with hemoptysis and chronic hemosputum -A retrospective, single center, observational study- - Study of therapeutic effectiveness in patients with hemoptysis and chronic hemosputum

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000042050

Enrollment

180

Registered

2020-10-08

Start date

2020-08-26

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

hemoptysis

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1) Hospitalized patients with hemoptysis and chronic hemosputum 2) Patients with hemoptysis and chronic hemosputum who received any treatment including medication, bronchoscopy, endovascular treatment, and surgical treatment.

Exclusion criteria

Exclusion criteria: 1) Patients without any laboratory or imaging studies before treatment 2) Other ineligible status judged by pulmonary physicians

Design outcomes

Primary

Measure	Time frame
Comparison of 1-year recurrence-free rate in patients with hemoptysis and chronic hemosputum due to tuberculosis, nontuberculous mycobacteriosis, pulmonary aspergillosis, bronchial ectasia, and cryptogenic hemoptysis.	—

Countries

Japan

Contacts

Public ContactNaoko Nagano

National Center for Global Health and Medicine Department of Respiratory Medicine

nmatsubara-tky@umin.ac.jp03-3202-7181

Outcome results